Latest pulmonary disease News

World-first study reveals why people with COPD are more susceptible to Covid
Cochrane Review highlights need for new interventions to improve chronic obstructive pulmonary disease
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
Dimerix receives R&D tax rebate for last financial year
Pharmac deal good news for New Zealanders
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps
Life-saving medicines unaffordable as PBS co-pay heads to $50 script
Why inflammation is important
ATAGI recommendations on use of Spikevax Covid vaccine in children aged 6 to 11 years
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
Premature birth linked to lung disease later in life
Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus
RACGP: Queensland pharmacy prescribing trial risks patient safety
Altered gene expression and cell interactions involved in COPD
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Black summer bushfires of 2019-20 led to huge health burden in NSW, study finds
Tezspire approved in US for severe asthma
During summer, hazardous mould species more abundant in rooms with windows
Biotron’s BIT225 effective against Covid in animal study
Researchers find new target to combat lung disease
Health impact of coronary heart disease decreases, but still has highest disease burden for Australians
University of Toronto researcher says ‘virtual care’ will keep patients out of hospital
$15 million for innovative health and medical research
$2m NHMRC success for Centenary Institute researchers
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
New and amended PBS listings to help thousands of Australians
‘Thanks for asking’: patient-centred research helps drive change in lung disease treatment
Humane Research Australia’s new report calls for transition to human-relevant smoke inhalation research
$5M grant to investigate relationship between gut and lung in respiratory disease
Health impacts of smoke from fires in Amazon
Think, work and be safe – make sure you have Clean Air. Clear Lungs. at your workplace
Tezepelumab granted Orphan Drug Designation in US for eosinophilic esophagitis
Cardiac patients get moving, thanks to digital innovation
Mortality rate declines during first year of pandemic: Australia
Higher levels of organic pollutants found in homes located near natural gas wells: University of Toronto study
New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution
How COVID-19 changed way Australians used health services in 2019-20
Link between COPD, emphysema and lung cancer could lead to new treatments
World AIDS Day 2020 – WHO calls for global solidarity to maintain HIV services
Gut microbiome link to deadly lung disease
Early-life events linked to lung health in young adulthood
Implantable sensor could measure bodily functions — and then safely biodegrade
Chronic diseases and public health failures fuelling COVID-19 pandemic: study
Healthy life expectancy across Australia on rise as latest global disease estimates revealed
Chronic disease and public health failures fuel COVID-19 pandemic
Call to increase public health funding to combat chronic disease crisis